A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

NCT00236067 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
440
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cephalon